Clinical Trial of Reconstruction After Proximal Gastrectomy

NCT05418920 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2022-07-05

No results posted yet for this study

Summary

1\) To explore a simple, safe, post-proximal gastrectomy reconstruction method with good absorption and digestive function in order to improve patients' postoperative quality of life; 2) To fill the gap in the comparison of clinical efficacy between left-open single-flap technique and double-flap technique in this specialized field in China; 3) To utilize the experience and foundation of gastrointestinal surgery in the treatment of gastric cancer and integrate the advantageous resources in China; 4) To establish a large-sample, multicenter randomized clinical study in order to promote the establishment and improvement of relevant norms of gastrointestinal reconstruction

Conditions

  • Esophagitis, Reflux

Interventions

PROCEDURE

left-opening single-flap technique

left-opening single-flap technique

PROCEDURE

double-flap group technique

double-flap group technique

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • General Hospital of Ningxia Medical University

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER
  • Oncogastroenterology Committee of Chinese

    lead OTHER

Principal Investigators

  • Nan Wang, MD · Tang-Du Hospital

  • Chao Zhang, MD · Henan Provincial People's Hospital

  • Lei Wang, MD · General Hospital of Ningxia Medical University

  • Renwei Chang, MD · The First Affiliated Hospital of Shanxi Medical University

  • Junjun She, MD · First Affiliated Hospital Xi'an Jiaotong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-07-31
Completion
2027-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05418920 on ClinicalTrials.gov